Salbutamol-d9 (Albuterol-d9) is a deuterium-labeled short-acting β2-adrenergic receptor agonist. It serves as a tracer and internal standard for quantitative analysis using techniques such as NMR, GC-MS, or LC-MS. The unlabeled compound, Salbutamol, is known to promote tumorigenesis in gastric cancer cells via the β2-AR/ERK/EMT pathway and can relax bronchial smooth muscle, which is pertinent for studies concerning bronchospasm related to asthma and chronic obstructive pulmonary disease.
- Deuterium-labeled compound for research applications.
- Functions as a tracer for quantitative analysis.
- Can be used as an internal standard in analytical methods.
- Supports research in areas like asthma and chronic obstructive pulmonary disease.
- Relevant for studies on tumorigenesis in gastric cancer cells.